Immune therapy shows promise in head and neck cancer trial
NCT ID NCT02641093
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests whether adding pembrolizumab, a drug that helps the immune system fight cancer, to standard surgery, radiation, and sometimes chemotherapy improves outcomes for people with head and neck cancer. About 96 participants who had surgery will receive pembrolizumab alongside radiation or chemoradiation. The goal is to see if this combination is safe and helps prevent the cancer from coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
University of Cincinnati Medical Center
Cincinnati, Ohio, 45219, United States
-
University of Louisville - James Graham Brown Cancer Center
Louisville, Kentucky, 40202, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.